Beijing SL Pharmaceutical Co., Ltd. (002038.SZ)
CNY 6.29
(1.78%)
CNY 6.29
(1.78%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 477.86 Million CNY | -19.82% |
| 2022 | 263.31 Million CNY | -42.45% |
| 2021 | 457.54 Million CNY | 10.82% |
| 2020 | 412.88 Million CNY | -26.39% |
| 2019 | 560.9 Million CNY | -17.71% |
| 2018 | 681.63 Million CNY | 9.65% |
| 2017 | 621.62 Million CNY | 22.56% |
| 2016 | 507.18 Million CNY | -22.78% |
| 2015 | 656.81 Million CNY | -15.84% |
| 2014 | 780.47 Million CNY | 19.22% |
| 2013 | 654.62 Million CNY | 17.93% |
| 2012 | 555.09 Million CNY | -6.4% |
| 2011 | 593.04 Million CNY | 110.62% |
| 2010 | 281.57 Million CNY | 7.12% |
| 2009 | 262.85 Million CNY | 14.79% |
| 2008 | 228.99 Million CNY | 64.21% |
| 2007 | 139.45 Million CNY | 142.81% |
| 2006 | 57.43 Million CNY | 49.51% |
| 2005 | 38.41 Million CNY | 8.79% |
| 2004 | 35.31 Million CNY | 6.33% |
| 2003 | 33.21 Million CNY | 52.01% |
| 2002 | 21.84 Million CNY | 5.94% |
| 2001 | 20.62 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 101.57 Million CNY | 323.79% |
| 2024 Q3 | -50.8 Million CNY | -562.53% |
| 2024 Q2 | 10.98 Million CNY | -89.19% |
| 2023 Q1 | 230.84 Million CNY | 1621.95% |
| 2023 Q2 | 119.5 Million CNY | -48.23% |
| 2023 Q3 | -5.74 Million CNY | -104.81% |
| 2023 Q4 | 23.96 Million CNY | 517.15% |
| 2023 FY | 211.13 Million CNY | -19.82% |
| 2022 Q2 | 75.95 Million CNY | -34.06% |
| 2022 Q3 | 51.47 Million CNY | -32.22% |
| 2022 Q4 | 13.4 Million CNY | -73.96% |
| 2022 FY | 263.31 Million CNY | -42.45% |
| 2022 Q1 | 115.18 Million CNY | 651.6% |
| 2021 Q3 | 143 Million CNY | -38.03% |
| 2021 Q4 | -20.88 Million CNY | -114.6% |
| 2021 FY | 457.54 Million CNY | 10.82% |
| 2021 Q2 | 230.75 Million CNY | 120.47% |
| 2021 Q1 | 104.66 Million CNY | 55.37% |
| 2020 Q3 | 122.7 Million CNY | -21.52% |
| 2020 Q1 | 66.45 Million CNY | 1925.21% |
| 2020 Q2 | 156.35 Million CNY | 135.27% |
| 2020 Q4 | 67.36 Million CNY | -45.1% |
| 2020 FY | 412.88 Million CNY | -26.39% |
| 2019 FY | 560.9 Million CNY | -17.71% |
| 2019 Q2 | 177.67 Million CNY | -21.01% |
| 2019 Q1 | 224.92 Million CNY | 184.56% |
| 2019 Q3 | 161.94 Million CNY | -8.86% |
| 2019 Q4 | -3.64 Million CNY | -102.25% |
| 2018 Q2 | 191.98 Million CNY | -7.82% |
| 2018 Q4 | 79.04 Million CNY | -60.93% |
| 2018 FY | 681.63 Million CNY | 9.65% |
| 2018 Q1 | 208.27 Million CNY | 10.49% |
| 2018 Q3 | 202.33 Million CNY | 5.39% |
| 2017 Q3 | 180.19 Million CNY | 57.54% |
| 2017 Q2 | 114.38 Million CNY | -17.44% |
| 2017 Q1 | 138.53 Million CNY | 36.32% |
| 2017 FY | 621.62 Million CNY | 22.56% |
| 2017 Q4 | 188.5 Million CNY | 4.61% |
| 2016 Q1 | 165.5 Million CNY | 116.08% |
| 2016 FY | 507.18 Million CNY | -22.78% |
| 2016 Q4 | 101.62 Million CNY | -16.1% |
| 2016 Q3 | 121.13 Million CNY | 1.87% |
| 2016 Q2 | 118.91 Million CNY | -28.15% |
| 2015 Q4 | 76.59 Million CNY | -48.9% |
| 2015 Q2 | 227.67 Million CNY | 12.35% |
| 2015 FY | 656.81 Million CNY | -15.84% |
| 2015 Q1 | 202.65 Million CNY | 5.14% |
| 2015 Q3 | 149.88 Million CNY | -34.17% |
| 2014 Q3 | 190.74 Million CNY | -8.82% |
| 2014 Q4 | 192.74 Million CNY | 1.05% |
| 2014 FY | 780.47 Million CNY | 19.22% |
| 2014 Q1 | 187.78 Million CNY | 16.3% |
| 2014 Q2 | 209.19 Million CNY | 11.4% |
| 2013 Q1 | 144.03 Million CNY | -4.19% |
| 2013 Q3 | 172.35 Million CNY | -2.5% |
| 2013 Q4 | 161.46 Million CNY | -6.32% |
| 2013 FY | 654.62 Million CNY | 17.93% |
| 2013 Q2 | 176.77 Million CNY | 22.73% |
| 2012 Q2 | 145.76 Million CNY | 28.79% |
| 2012 Q1 | 113.17 Million CNY | 31.26% |
| 2012 Q4 | 150.34 Million CNY | 3.11% |
| 2012 FY | 555.09 Million CNY | -6.4% |
| 2012 Q3 | 145.81 Million CNY | 0.03% |
| 2011 FY | 593.04 Million CNY | 110.62% |
| 2011 Q4 | 86.22 Million CNY | -17.72% |
| 2011 Q3 | 104.78 Million CNY | -66.75% |
| 2011 Q1 | 86.83 Million CNY | 38.89% |
| 2011 Q2 | 315.19 Million CNY | 262.96% |
| 2010 Q1 | 64.18 Million CNY | 24.45% |
| 2010 FY | 281.57 Million CNY | 7.12% |
| 2010 Q2 | 86.71 Million CNY | 35.1% |
| 2010 Q3 | 68.15 Million CNY | -21.41% |
| 2010 Q4 | 62.52 Million CNY | -8.25% |
| 2009 FY | 262.85 Million CNY | 14.79% |
| 2009 Q4 | 51.57 Million CNY | -36.84% |
| 2009 Q3 | 81.66 Million CNY | 4.84% |
| 2009 Q2 | 77.89 Million CNY | 50.58% |
| 2009 Q1 | 51.72 Million CNY | 11.59% |
| 2008 Q4 | 46.35 Million CNY | -41.86% |
| 2008 Q3 | 79.72 Million CNY | 22.92% |
| 2008 Q2 | 64.86 Million CNY | 70.48% |
| 2008 Q1 | 38.04 Million CNY | -0.11% |
| 2008 FY | 228.99 Million CNY | 64.21% |
| 2007 Q1 | 25.12 Million CNY | 49.54% |
| 2007 FY | 139.45 Million CNY | 142.81% |
| 2007 Q4 | 38.08 Million CNY | -18.95% |
| 2007 Q3 | 46.99 Million CNY | 60.71% |
| 2007 Q2 | 29.24 Million CNY | 16.37% |
| 2006 Q1 | 10.51 Million CNY | 81.57% |
| 2006 Q2 | 13.6 Million CNY | 29.39% |
| 2006 FY | 57.43 Million CNY | 49.51% |
| 2006 Q3 | 16.5 Million CNY | 21.34% |
| 2006 Q4 | 16.8 Million CNY | 1.79% |
| 2005 Q1 | 7.52 Million CNY | -20.04% |
| 2005 Q2 | 10.68 Million CNY | 41.92% |
| 2005 FY | 38.41 Million CNY | 8.79% |
| 2005 Q3 | 14.41 Million CNY | 34.91% |
| 2005 Q4 | 5.79 Million CNY | -59.82% |
| 2004 Q3 | 10.05 Million CNY | 15.09% |
| 2004 Q2 | 8.73 Million CNY | 22.77% |
| 2004 Q4 | 9.41 Million CNY | -6.34% |
| 2004 FY | 35.31 Million CNY | 6.33% |
| 2004 Q1 | 7.11 Million CNY | -7.27% |
| 2003 Q4 | 7.67 Million CNY | -14.05% |
| 2003 FY | 33.21 Million CNY | 52.01% |
| 2003 Q3 | 8.92 Million CNY | 0.0% |
| 2002 FY | 21.84 Million CNY | 5.94% |
| 2001 FY | 20.62 Million CNY | 0.0% |